A group including CD&R and existing lenders, including HPS Investment Partners, agreed to a deal that will inject $225 ...

Resideo Technologies (REZI) has disclosed a new risk, in the Share Price & Shareholder Rights category. The CD&R Stockholder, holding ...

The renewed negotiations come after CD&R agreed to pledges around local jobs, investments and production, Bloomberg reported earlier. Sanofi encountered a backlash in France when it chose the US ...

PARIS, Oct 21 (Reuters) - French drugmaker Sanofi (SASY.PA), opens new tab said on Monday it had entered exclusive talks to sell a 50% controlling stake in its consumer health business Opella to U ...

The US buyout firm is pairing with the French pharma giant to buy out its consumer unit. Success here requires much more than cutting costs. Chris Hughes is a Bloomberg Opinion columnist covering ...

Cloudera, which is backed by Clayton, Dubilier & Rice, has agreed to acquire Octopai’s data lineage and catalog platform. Based in Wilmington, Delaware, Octopai is an automated metadata management ...

Clayton, Dubilier & Rice ("CD&R" or the "Firm") today announced that Bill Galvin has been engaged as an Operating Advisor to ...

The deal would allow Sanofi to focus on its more lucrative, but riskier, innovative drugs and vaccines, and CD&R to take a 50% controlling stake in a business that is home to brands such as ...

Sanofi, France's biggest pharmaceutical group, said last week that it was in talks with CD&R for the sale of a 50% controlling stake in Opella, triggering criticism from government opponents over the ...

Sanofi and CD&R are joining forces to fuel Opella’s ambitions as a French-headquartered, global consumer healthcare champion. Sanofi and CD&R have entered exclusive negotiations for the ...

Vialto Partners, a provider of tax and immigration services, has agreed to restructure its debt a little more than two years after the company spun out of PricewaterhouseCoopers and was acquired by ...